Biktarvy Interactions
There are 443 drugs known to interact with Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 187 are major, 254 are moderate, and 2 are minor.
- View all 443 medications that may interact with Biktarvy
- View Biktarvy alcohol/food interactions (2)
- View Biktarvy disease interactions (9)
Most frequently checked interactions
View interaction reports for Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) and the medicines listed below.
- acyclovir
- albuterol
- amlodipine
- aspirin
- atorvastatin
- bupropion
- buspirone
- cetirizine
- clonazepam
- doxycycline
- famotidine
- finasteride
- gabapentin
- hydroxyzine
- ibuprofen
- lisinopril
- losartan
- metformin
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- pantoprazole
- rosuvastatin
- sertraline
- tadalafil
- tamsulosin
- trazodone
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Biktarvy alcohol/food interactions
There are 2 alcohol/food interactions with Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide).
Biktarvy disease interactions
There are 9 disease interactions with Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) which include:
- hepatic dysfunction
- renal dysfunction
- hepatitis B
- hepatotoxicity
- hemodialysis
- renal dysfunction
- bone toxicity
- liver disease
- renal dysfunction
More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Biktarvy consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (221)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.